The Significant Global Impact of Atopic Dermatitis on Older Adults

Recent studies highlight that atopic dermatitis (AD), a common chronic skin condition, poses a substantial health burden in the older adult population worldwide. According to a comprehensive analysis published in Frontiers in Public Health, the prevalence of AD among individuals aged 60 and above has risen markedly from 1990 to 2021, with an estimated 11 million cases globally. This increase is primarily driven by population growth, even though age-standardized rates have seen a decline.

The research team, led by Yi Ou from Chongqing Medical University in China, evaluated data from the Global Burden of Diseases Study 2021 to project future trends until 2050. Their findings reveal that while the number of cases, incidence, and disability-adjusted life-years (DALYs) related to AD are expected to continue climbing, the age-standardized DALY rates are predicted to decrease. Notably, women and those aged 75-79 show higher incidence rates, emphasizing gender and age-specific vulnerabilities.

This rising trend underscores AD as an underestimated public health concern, affecting older adults differently across regions and socioeconomic levels. The relationship between higher sociodemographic development and increased AD burden suggests disparities in disease recognition and management. As the aging population grows, the need for targeted prevention and treatment strategies becomes increasingly urgent to mitigate the long-term health impacts of AD in this vulnerable group.

Addressing this challenge requires public health initiatives focusing on early diagnosis, effective management, and education tailored to older adults. Recognizing the growing influence of AD on the health of seniors worldwide is crucial for healthcare providers, policymakers, and researchers working toward improved quality of life for aging populations.

Source: https://medicalxpress.com/news/2025-05-global-burden-atopic-dermatitis-older.html